Observational study finds 79.1% COVID-19 vaccination initiation in U.S. adults aged 65+

An observational study examined COVID-19 vaccination initiation among adults aged 65 years and older in the United States. The study period covered the initial vaccine rollout from December 14, 2020, to April 10, 2021. The intervention was the national COVID-19 vaccination program, with no specific comparator reported. The primary outcome was receipt of at least one vaccine dose.

The main finding was that 79.1% of adults in this age group had initiated vaccination by the end of the study period. The study also reported higher vaccination initiation among men compared to women. At the county level, an inverse association was observed: counties with lower vaccination initiation rates had higher percentages of older adults with social vulnerabilities. No specific effect sizes, absolute numbers, or confidence intervals were reported for these associations.

No safety, tolerability, or adverse event data were reported for this observational analysis. Key limitations include the observational design, which can only show associations, not establish causation. The findings are specific to U.S. adults aged 65+ during the initial vaccine rollout period and may not be generalizable to other populations or timeframes. The study did not report specific effect sizes, funding sources, or conflicts of interest.

For clinical practice, this analysis provides a descriptive snapshot of early vaccine uptake in a high-priority age group and highlights demographic and geographic disparities. The association between lower county-level initiation and higher social vulnerability suggests areas where targeted outreach may be needed. Clinicians should interpret these findings as associations from a specific time period, not as evidence of causal relationships or predictors of long-term vaccine coverage.